Kainic acid-induced neurodegenerative model: Potentials and limitations

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Zhu, Jie ^a,b   Zheng, Xiang Yu ^a,b   Zhang, Hong Liang ^a,b   Luo, Qi ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; KAINIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; RANTES; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; KAINIC ACID RECEPTOR;

ALZHEIMER DISEASE; BEHAVIOR CHANGE; BRAIN DAMAGE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CLINICAL EVALUATION; COMPLEX PARTIAL SEIZURE; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DISEASE MODEL; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM STRESS; EPILEPTIC STATE; EXCITOTOXICITY; GLIA CELL; HIPPOCAMPUS; IMMUNE RESPONSE; INFLAMMATION; MICROGLIA; NONHUMAN; OXIDATIVE STRESS; REVIEW; SEIZURE; ANIMAL; CHEMICALLY INDUCED DISORDER; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; DISEASE MODELS, ANIMAL; KAINIC ACID; NEURODEGENERATIVE DISEASES; RECEPTORS, KAINIC ACID; SIGNAL TRANSDUCTION;

EID: 79251560611     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/457079     Document Type: Review

References (120)

1. Vincent P., Mulle C., Kainate receptors in epilepsy and excitotoxicity Neuroscience 2009 158 1 309 323
2. Wang Q., Yu S., Simonyi A., Sun G. Y., Sun A. Y., Kainic acid-mediated excitotoxicity as a model for neurodegeneration Molecular Neurobiology 2005 31 13 3 16
3. Kew J. N. C., Kemp J. A., Ionotropic and metabotropic glutamate receptor structure and pharmacology Psychopharmacology 2005 179 1 4 29
4. Collingridge G. L., Olsen R. W., Peters J., Spedding M., A nomenclature for ligand-gated ion channels Neuropharmacology 2009 56 1 2 5
5. Ben-Ari Y., Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy Neuroscience 1985 14 2 375 403
6. Mulle C., Sailer A., Prez-Otao I., Dickinson-Anson H., Castillo P. E., Bureau I., Maron C., Gage F. H., Mann J. R., Bettler B., Heinemann S. F., Altered synaptic physiology and reduced susceptibility to kainate- induced secures in GluR6-deficient mice Nature 1998 392 6676 601 605
7. Chuang Y.-C., Chang A. Y. W., Lin J.-W., Hsu S.-P., Chan S. H. H., Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat Epilepsia 2004 45 10 1202 1209
8. Ratt S., Lacaille J. C., Selective degeneration and synaptic reorganization of hippocampal interneurons in a chronic model of temporal lobe epilepsy Advances in Neurology 2006 97 69 76
9. Grticke I., Hoffmann K., Lscher W., Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate Experimental Neurology 2008 213 1 71 83
10. Gobbo O. L., O'Mara S. M., Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration Neuroscience 2004 125 2 317 327
11. Gobbo O. L., O'Mara S. M., Exercise, but not environmental enrichment, improves learning after kainic acid-induced hippocampal neurodegeneration in association with an increase in brain-derived neurotrophic factor Behavioural Brain Research 2005 159 1 21 26
12. Jarrard L. E., Use of excitotoxins to lesion the hippocampus: update Hippocampus 2002 12 3 405 414
13. Bloss E. B., Hunter R. G., Hippocampal kainate receptors Vitamins and Hormones 2010 82 167 184
14. Carriedo S. G., Sensi S. L., Yin H. Z., Weiss J. H., AMPA exposures induce mitochondrial Ca 2+ overload and ROS generation in spinal motor neurons in vitro Journal of Neuroscience 2000 20 1 240 250
15. Lauri S. E., Bortolotto Z. A., Bleakman D., Ornstein P. L., Lodge D., Isaac J. T. R., Collingridge G. L., A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP Neuron 2001 32 4 697 709
16. Contractor A., Sailer A. W., Darstein M., Maron C., Xu J., Swanson G. T., Heinemann S. F., Loss of kainate receptor-mediated heterosynaptic facilitation of mossy-fiber synapses in KA2-/- mice Journal of Neuroscience 2003 23 2 422 429
17. Rodrguez-Moreno A., Sihra T. S., Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus Journal of Physiology 2004 557 3 733 745
18. Lee H. N., Jeon G. S., Kim D. W., Cho I.-H., Cho S. S., Expression of adenomatous polyposis coli protein in reactive astrocytes in hippocampus of kainic acid-induced rat Neurochemical Research 2009 35 1 114 121 1 8
19. McLin J. P., Steward O., Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains European Journal of Neuroscience 2006 24 8 2191 2202
20. Kasugai M., Akaike K., Imamura S.-I., Matsukubo H., Tojo H., Nakamura M., Tanaka S., Sano A., Differences in two mice strains on kainic acid-induced amygdalar seizures Biochemical and Biophysical Research Communications 2007 357 4 1078 1083
21. Pereno G. L., Beltramino C. A., Differential role of gonadal hormones on kainic acid-induced neurodegeneration in medial amygdaloid nucleus of female and male rats Neuroscience 2009 163 3 952 963
22. Sokka A.-L., Putkonen N., Mudo G., Pryazhnikov E., Reijonen S., Khiroug L., Belluardo N., Lindholm D., Korhonen L., Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain Journal of Neuroscience 2007 27 4 901 908
23. De Lemos L., Junyent F., Verdaguer E., Folch J., Romero R., Palls M., Ferrer I., Auladell C., Camins A., Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment Journal of Neurochemistry 2010 114 5 1315 1322
24. Cho I.-H., Hong J., Suh E. C., Kim J. H., Lee H., Lee J. E., Lee S., Kim C.-H., Kim D. W., Jo E.-K., Lee K. E., Karin M., Lee S. J., Role of microglial IKK in kainic acid-induced hippocampal neuronal cell death Brain 2008 131 11 3019 3033
25. Chen Z., Duan R.-S., Quezada H. C., Mix E., Nennesmo I., Adem A., Winblad B., Zhu J., Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice Journal of Neurobiology 2005 62 2 207 218
26. Ravizza T., Rizzi M., Perego C., Richichi C., Velskv J., Mosh S. L., De Simoni M. G., Vezzani A., Inflammatory response and glia activation in developing rat hippocampus after status epilepticus Epilepsia 2005 46 supplement 5 113 117
27. Mack C. L., Vanderlugt-Castaneda C. L., Neville K. L., Miller S. D., Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis Journal of Neuroimmunology 2003 144 1-2 68 79
28. Kato H., Walz W., The initiation of the microglial response Brain Pathology 2000 10 1 137 143
29. Napoli I., Neumann H., Protective effects of microglia in multiple sclerosis Experimental Neurology 2009 225 1 24 28
30. Marinova-Mutafchieva L., Sadeghian M., Broom L., Davis J. B., Medhurst A. D., Dexter D. T., Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease Journal of Neurochemistry 2009 110 3 966 975
31. Venneti S., Wiley C. A., Kofler J., Imaging microglial activation during neuroinflammation and Alzheimer's disease Journal of Neuroimmune Pharmacology 2009 4 2 227 243
32. Penkowa M., Molinero A., Carrasco J., Hidalgo J., Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures Neuroscience 2001 102 4 805 818
33. Byun J.-S., Lee J.-W., Kim S. Y., Kwon K. J., Sohn J.-H., Lee K., Oh D., Kim S.-S., Chun W., Lee H. J., Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice Peptides 2010 31 11 2094 2099
34. Giaume C., Kirchhoff F., Matute C., Reichenbach A., Verkhratsky A., Glia: the fulcrum of brain diseases Cell Death and Differentiation 2007 14 7 1324 1335
35. Gill S. S., Hou Y., Ghane T., Pulido O. M., Regional susceptibility to domoic acid in primary astrocyte cells cultured from the brain stem and hippocampus Marine Drugs 2008 6 1 25 38
36. Vesce S., Rossi D., Brambilla L., Volterra A., Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation International Review of Neurobiology 2007 82 57 71
37. Braun A., Dang J., Johann S., Beyer C., Kipp M., Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins Neurochemistry International 2009 55 7 610 618
38. Dakubo G. D., Beug S. T., Mazerolle C. J., Thurig S., Wang Y., Wallace V. A., Control of glial precursor cell development in the mouse optic nerve by sonic hedgehog from retinal ganglion cells Brain Research 2008 1228 C 27 42
39. Sandhu J. K., Gardaneh M., Iwasiow R., Lanthier P., Gangaraju S., Ribecco-Lutkiewicz M., Tremblay R., Kiuchi K., Sikorska M., Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity Neurobiology of Disease 2009 33 3 405 414
40. Brand-Schieber E., Werner P., AMPA/kainate receptors in mouse spinal cord cell-specific display of receptor subunits by oligodendrocytes and astrocytes and at the nodes of Ranvier GLIA 2003 42 1 12 24
41. Heneka M. T., Rodrguez J. J., Verkhratsky A., Neuroglia in neurodegeneration Brain Research Reviews 2010 63 1-2 189 211
42. Bendotti C., Guglielmetti F., Tortarolo M., Samanin R., Hirst W. D., Differential expression of S100 and glial fibrillary acidic protein in the hippocampus after kainic acid-induced lesions and mossy fiber sprouting in adult rat Experimental Neurology 2000 161 1 317 329
43. Ding M., Haglid K. G., Hamberger A., Quantitative immunochemistry on neuronal loss, reactive gliosis and BBB damage in cortex/striatum and hippocampus/amygdala after systemic kainic acid administration Neurochemistry International 2000 36 4-5 313 318
44. Saito A., Hino S.-I., Murakami T., Kondo S., Imaizumi K., A novel ER stress transducer, OASIS, expressed in astrocytes Antioxidants and Redox Signaling 2007 9 5 563 571
45. Chihara K., Saito A., Murakami T., Hino S.-I., Aoki Y., Sekiya H., Aikawa Y., Wanaka A., Imaizumi K., Increased vulnerability of hippocampal pyramidal neurons to the toxicity of kainic acid in OASIS-deficient mice Journal of Neurochemistry 2009 110 3 956 965
46. Vargas M. R., Johnson D. A., Sirkis D. W., Messing A., Johnson J. A., Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis Journal of Neuroscience 2008 28 50 13574 13581
47. Vargas M. R., Johnson J. A., The Nrf2-ARE cytoprotective pathway in astrocytes Expert Reviews in Molecular Medicine 2009 11, article no. e17
48. Campbell S. L., Mathew S. S., Hablitz J. J., Pre- and postsynaptic effects of kainate on layer II/III pyramidal cells in rat neocortex Neuropharmacology 2007 53 1 37 47
49. Youn D.-H., Randi M., Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit Journal of Physiology 2004 555 3 683 698
50. Brorson J. R., Manzolillo P. A., Miller R. J., Ca 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells Journal of Neuroscience 1994 14 1 187 197
51. Frantseva M. V., Perez Velazquez J. L., Tsoraklidis G., Mendonca A. J., Adamchik Y., Mills L. R., Carlen P. L., Burnham M. W., Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy Neuroscience 2000 97 3 431 435
52. Swamy M., Sirajudeen K. N.S., Chandran G., Nitric oxide (NO), citrullineNO cycle enzymes, glutamine synthetase, and oxidative status in kainic acid-mediated excitotoxicity in rat brain Drug and Chemical Toxicology 2009 32 4 326 331
53. Nakaki T., Mishima A., Suzuki E., Shintani F., Fujii T., Glufosinate ammonium stimulates nitric oxide production through N-methyl D-aspartate receptors in rat cerebellum Neuroscience Letters 2000 290 3 209 212
54. Prast H., Philippu A., Nitric oxide as modulator of neuronal function Progress in Neurobiology 2001 64 1 51 68
55. Ueda Y., Yokoyama H., Nakajima A., Tokumaru J., Doi T., Mitsuyama Y., Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus Experimental Brain Research 2002 147 2 219 226
56. Kim E. J., Lee J. E., Kwon K. J., Lee S. H., Moon C.-H., Baik E. J., Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E 2 production and neurodegeneration in cortical and hippocampal cell cultures Brain Research 2001 908 1 1 9
57. Takemiya T., Matsumura K., Yamagata K., Roles of prostaglandin synthesis in excitotoxic brain diseases Neurochemistry International 2007 51 24 112 120
58. Takemiya T., Maehara M., Matsumura K., Yasuda S., Sugiura H., Yamagata K., Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region Neuroscience Research 2006 56 1 103 110
59. Kawaguchi K., Hickey R. W., Rose M. E., Zhu L., Chen J., Graham S. H., Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus Brain Research 2005 1050 1-2 130 137
60. Patel M., Liang L.-P., Hou H., Williams B. B., Kmiec M., Swartz H. M., Fessel J. P., Roberts L. J. II, Seizure-induced formation of isofurans: novel products of lipid peroxidation whose formation is positively modulated by oxygen tension Journal of Neurochemistry 2008 104 1 264 270
61. Rojo L. E., Fernndez J. A., Maccioni A. A., Jimenez J. M., Maccioni R. B., Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease Archives of Medical Research 2008 39 1 1 16
62. Bennett J. L., Stve O., Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications Clinical Neuropharmacology 2009 32 3 121 132
63. Colton C. A., Wilcock D. M., Assessing activation states in microglia CNS and Neurological Disorders 2010 9 2 174 191
64. Kerschensteiner M., Meinl E., Hohlfeld R., Neuro-immune crosstalk in CNS diseases Neuroscience 2009 158 3 1122 1132
65. Chen Z., Duan R.-S., Concha Q. H., Wu Q., Mix E., Winblad B., Ljunggren H.-G., Zhu J., IL-12p35 deficiency alleviates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice Neurobiology of Disease 2004 17 2 171 178
66. Stuehr D. J., Cho H. J., Kwon N. S., Weise M. F., Nathan C. F., Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein Proceedings of the National Academy of Sciences of the United States of America 1991 88 17 7773 7777
67. Wiesinger H., Arginine metabolism and the synthesis of nitric oxide in the nervous system Progress in Neurobiology 2001 64 4 365 391
68. Hanisch U.-K., Microglia as a source and target of cytokines GLIA 2002 40 2 140 155
69. Amor S., Puentes F., Baker D., Van Der Valk P., Inflammation in neurodegenerative diseases Immunology 2010 129 2 154 169
70. Byun J.-S., Lee S.-H., Jeon S.-H., Kwon Y.-S., Hee J. L., Kim S.-S., Kim Y.-M., Kim M.-J., Chun W., Kainic acid-induced neuronal death is attenuated by aminoguanidine but aggravated by L-NAME in mouse hippocampus Korean Journal of Physiology and Pharmacology 2009 13 4 265 271
71. Yamamoto M., Yoshizaki K., Kishimoto T., Ito H., IL-6 is required for the development of Th1 cell-mediated murine colitis Journal of Immunology 2000 164 9 4878 4882
72. Diehl S., Rincn M., The two faces of IL-6 on Th1/Th2 differentiation Molecular Immunology 2002 39 9 531 536
73. Lehtimki K. A., Peltola J., Koskikallio E., Kernen T., Honkaniemi J., Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures Molecular Brain Research 2003 110 2 253 260
74. All C., Nicole O., Docagne F., Lesne S., MacKenzie E. T., Nouvelot A., Buisson A., Vivien D., Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitoxicity in the brain Journal of Cerebral Blood Flow and Metabolism 2000 20 6 956 966
75. De Sarro G., Russo E., Ferreri G., Giuseppe B., Flocco M. A., Di Paola E. D., De Sarro A., Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice Pharmacology Biochemistry and Behavior 2004 77 4 761 766
76. Penkowa M., Molinero A., Carrasco J., Hidalgo J., Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures Neuroscience 2001 102 4 805 818
77. Stoll G., Jander S., Schroeter M., Cytokines in CNS disorders: neurotoxicity versus neuroprotection Journal of Neural Transmission 2000 59, supplement 81 89
78. Zhang X.-M., Duan R.-S., Chen Z., Quezada H. C., Mix E., Winblad B., Zhu J., IL-18 deficiency aggravates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice due to an overcompensation by IL-12 Experimental Neurology 2007 205 1 64 73
79. Kiefer R., Streit W. J., Toyka K. V., Kreutzberg G. W., Hartung H.-P., Transforming growth factor- 1: a lesion-associated cytokine of the nervous system International Journal of Developmental Neuroscience 1995 13 3-4 331 339
80. Boche D., Cunningham C., Gauldie J., Perry V. H., Transforming growth factor- 1-mediated neuroprotection against excitotoxic injury in vivo Journal of Cerebral Blood Flow and Metabolism 2003 23 10 1174 1182
81. Morgan T. E., Nichols N. R., Pasinetti G. M., Finch C. E., TGF- 1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration Experimental Neurology 1993 120 2 291 301
82. Kim H.-C., Bing G., Kim S.-J., Jhoo W.-K., Shin E.-J., Wie M. B., Ko K. H., Kim W.-K., Flanders K. C., Choi S.-G., Hong J.-S., Kainate treatment alters TGF- 3 gene expression in the rat hippocampus Molecular Brain Research 2002 108 1-2 60 70
83. Lu M.-O., Zhang X.-M., Mix E., Quezada H. C., Jin T., Zhu J., Adem A., TNF- receptor 1 deficiency enhances kainic acid-induced hippocampal injury in mice Journal of Neuroscience Research 2008 86 7 1608 1614
84. Thompson C., Gary D., Mattson M., Mackenzie A., Robertson G. S., Kainic acid-induced naip expression in the hippocampus is blocked in mice lacking TNF receptors Molecular Brain Research 2004 123 1-2 126 131
85. Balosso S., Ravizza T., Perego C., Peschon J., Campbell I. L., De Simoni M. G., Vezzani A., Tumor necrosis factor- inhibits seizures in mice via p75 receptors Annals of Neurology 2005 57 6 804 812
86. Zhu W., Zheng H., Shao X., Wang W., Yao Q., Li Z., Excitotoxicity of TNF derived from KA activated microglia on hippocampal neurons in vitro and in vivo Journal of Neurochemistry 2010 114 2 386 396
87. Kanno T., Nagata T., Yamamoto S., Okamura H., Nishizaki T., Interleukin-18 stimulates synaptically released glutamate and enhances postsynaptic AMPA receptor responses in the CA1 region of mouse hippocampal slices Brain Research 2004 1012 1-2 190 193
88. Sugama S., Wirz S. A., Barr A. M., Conti B., Bartfai T., Shibasaki T., Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine treatment Neuroscience 2004 128 2 451 458
89. Jeon G. S., Park S. K., Park S. W., Kim D. W., Chung C. K., Cho S. S., Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus Neurochemical Research 2008 33 1 179 184
90. Wang D., Zhang S., Li L., Liu X., Mei K., Wang X., Structural insights into the assembly and activation of IL-1 2 with its receptors Nature Immunology 2010 11 10 905 911
91. Oprica M., Eriksson C., Schultzberg M., Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system Journal of Cellular and Molecular Medicine 2003 7 2 127 140
92. Liu B., Hong J.-S., Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention Journal of Pharmacology and Experimental Therapeutics 2003 304 1 1 7
93. Zheng H., Zhu W., Zhao H., Wang X., Wang W., Li Z., Kainic acid-activated microglia mediate increased excitability of rat hippocampal neurons in vitro and in vivo: crucial role of interleukin-1beta NeuroImmunoModulation 2009 17 1 31 38
94. Chen Z., Ljunggren H.-G., Bogdanovic N., Nennesmo I., Winblad B., Zhu J., Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice Brain Research 2002 931 2 135 145
95. Illum L., Transport of drugs from the nasal cavity to the central nervous system European Journal of Pharmaceutical Sciences 2000 11 1 1 18
96. Montague A. A., Greer C. A., Differential distribution of ionotropic glutamate receptor subunits in the rat olfactory bulb Journal of Comparative Neurology 1999 405 2 233 246
97. Mathison S., Nagilla R., Kompella U. B., Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? Journal of Drug Targeting 1998 5 6 415 441
98. Sakane T., Akizuki M., Taki Y., Yamashita S., Sezaki H., Nadai T., Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs Journal of Pharmacy and Pharmacology 1995 47 5 379 381
99. Genter M. B., Kendig E. L., Knutson M. D., Uptake of materials from the nasal cavity into the blood and brain: are we finally beginning to understand these processes at the molecular level Annals of the New York Academy of Sciences 2009 1170 1 623 628
100. Johnson K. A., Conn P. J., Niswender C. M., Glutamate receptors as therapeutic targets for Parkinson's disease CNS and Neurological Disorders 2009 8 6 475 491
101. Ilieva H., Polymenidou M., Cleveland D. W., Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond Journal of Cell Biology 2009 187 6 761 772
102. Kim D. H., Yoon B. H., Jung W. Y., Kim J. M., Park S. J., Park D. H., Huh Y., Park C., Cheong J. H., Lee K.-T., Shin C. Y., Ryu J. H., Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice Neuropharmacology 2010 59 1-2 20 30
103. Miyamoto R., Shimakawa S., Suzuki S., Ogihara T., Tamai H., Edaravone prevents kainic acid-induced neuronal death Brain Research 2008 1209 1 85 91
104. Chung S.-Y., Han S.-H., Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition Journal of Pineal Research 2003 34 2 95 102
105. Zhu X.-L., Xiong L.-Z., Wang Q., Liu Z.-G., Ma X., Zhu Z.-H., Hu S., Gong G., Chen S.-Y., Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats Neuroscience Letters 2009 449 1 24 27
106. Li S.-Y., Jia Y.-H., Sun W.-G., Tang Y., An G.-S., Ni J.-H., Jia H.-T., Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus Free Radical Biology and Medicine 2010 48 4 597 608
107. Swanson G. T., Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon? Neuropsychopharmacology 2009 34 1 249 250
108. Liu X.-M., Pei D.-S., Guan Q.-H., Sun Y.-F., Wang X.-T., Zhang Q.-X., Zhang G.-Y., Neuroprotection of Tat-GluR6-9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways Journal of Biological Chemistry 2006 281 25 17432 17445
109. Pei D.-S., Wang X.-T., Liu Y., Sun Y.-F., Guan Q.-H., Wang W., Yan J.-Z., Zong Y.-Y., Xu T.-L., Zhang G.-Y., Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence Brain 2006 129 2 465 479
110. Akashiba H., Matsuki N., Nishiyama N., Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons Journal of Neurochemistry 2006 99 3 733 744
111. Akashiba H., Matsuki N., Nishiyama N., p27 small interfering RNA induces cell death through elevating cell cycle activity in cultured cortical neurons: a proof-of-concept study Cellular and Molecular Life Sciences 2006 63 19-20 2397 2404
112. Ueyama C., Akashiba H., Nakayama K., Nakayama K. I., Nishiyama N., Matsuki N., Ablation of p27 enhance kainate-induced seizure and hippocampal degeneration NeuroReport 2007 18 17 1781 1785
113. Arajo I. M., Gil J. M., Carreira B. P., Mohapel P., Petersen., Pinheiro P. S., Soulet D., Bahr B. A., Brundin P., Carvalho C. M., Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus Journal of Neurochemistry 2008 105 3 666 676
114. Verdaguer E., Jord E. G., Canudas A. M., Jimnez A., Folch J., Rimbau V., Palls M., Camins A., p21WAF1/Cip1 is not involved in kainic acid-induced apoptosis in murine cerebellar granule cells Brain Research 2004 1030 2 297 302
115. Verdaguer E., Garca-Jord E., Jimnez A., Stranges A., Sureda F. X., Canudas A. M., Escubedo E., Camarasa J., Palls M., Camins A., Kainic acid-induced neuronal cell death in cerebellar granule cells is not prevented by caspase inhibitors British Journal of Pharmacology 2002 135 5 1297 1307
116. Jinap S., Hajeb P., Glutamate. Its applications in food and contribution to health Appetite 2010 55 1 1 10
117. Yang J., Houk B., Shah J., Hauser K. F., Luo Y., Smith G., Schauwecker E., Barnes G. N., Genetic background regulates semaphorin gene expression and epileptogenesis in mouse brain after kainic acid status epilepticus Neuroscience 2005 131 4 853 869
118. Aarts M. M., Tymianski M., Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors Biochemical Pharmacology 2003 66 6 877 886
119. Thukral V., Chikaraishi D., Hunter D. D., Wang J. K. T., Expression of non-N-methyl-D-aspartate glutamate receptor subunits in the olfactory epithelium Neuroscience 1997 79 2 411 424
120. Schauwecker P. E., Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain Experimental Neurology 2010 224 1 207 218